Moderna Looks to Pare R&D Spending Even as It Pivots From Covid Vaccines
Wall Street Journal
The biotech company is advancing new offerings in part to offset revenue declines while also trying to bring costs down.
Wall Street Journal
The biotech company is advancing new offerings in part to offset revenue declines while also trying to bring costs down.